RxDoctor Payments Data

Michael Gazes

Foot & Ankle Surgery · West Haven, CTNPI 1962820522

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for foot & ankle surgery clinicians in CT, where the typical reported total is $1,838.

$771in general payments, 2019–2025

Across 12 payments — averaging $64.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$122
  • Osiris Therapeutics Inc.$116
  • Misonix Inc$114
  • Bone Support Inc.$113
  • Organogenesis Inc.$104
  • Stryker$85
  • plus $118 from 2 others
$50,000in ownership & investment interests, 2019–2025

Across 7 payments — averaging $7142.86 each. An ownership or investment interest held by the physician or an immediate family member.

  • Gramercy Extremity Orthopedics LLC$50K

What the payments were for

  • Food & beverage$771100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew2$122
Osiris Therapeutics Inc.2$116
Misonix Inc1$114
Bone Support Inc.1$113
Organogenesis Inc.1$104
Stryker1$85
Polaris Technology Solutions LLC2$64
Johnson & Johnson2$54

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$771 in reported general payments places this provider in the 30th percentile of 89 foot & ankle surgery providers in Connecticut.

See all foot & ankle surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$248,955
Medicare patients
436
Services billed
2,787

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate20$764
Ammonium Lactate23$495
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav25$227
Clotrimazole16$188
Doxycycline Hyclate17$131
Terbinafine Hcl12$100

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in West Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →